Full Name
TAN ENG KING
Variants
Tan, E.-K.
Tan, E.K.
 
Main Affiliation
 
 
Email
gmstek@nus.edu.sg
 

Results 1-20 of 393 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
12000A case-controlled MRI/MRA study of neurovascular contact in hemifacial spasm [3] (multiple letters)Tan E.-K. ; Chan L.-L.; Jankovic J.; Ho S.L.; Cheng P.W.; Wong W.C.
21997A comparative study of the distribution of ofloxacin and ciprofloxacin in prostatic tissues after simultaneous oral ingestionPng J.C.D.; Tan E. ; Foo K.T.; Li M.K.; Cheng C.; Rekhraj I.R.
32011A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's diseaseKrüger R.; Sharma M.; Riess O.; Gasser T.; Van Broeckhoven C.; Theuns J.; Aasly J.; Annesi G.; Bentivoglio A.R.; Brice A.; Djarmati A.; Elbaz A.; Farrer M.; Ferrarese C.; Gibson J.M.; Hadjigeorgiou G.M.; Hattori N.; Ioannidis J.P.A.; Jasinska-Myga B.; Klein C.; Lambert J.-C.; Lesage S.; Lin J.-J.; Lynch T.; Mellick G.D.; de Nigris F.; Opala G.; Prigione A.; Quattrone A.; Ross O.A.; Satake W.; Silburn P.A.; Tan E.K. ; Toda T.; Tomiyama H.; Wirdefeldt K.; Wszolek Z.; Xiromerisiou G.; Maraganore D.M.
42015A longitudinal study of non-motor symptom burden in Parkinson's disease after a transition to expert carePrakash K.M. ; Nadkarni N.V. ; Lye W.-K. ; Yong M.-H.; Chew L.-M.; Tan E.-K. 
52012A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variantsSharma M.; Ioannidis J.P.A.; Aasly J.O.; Annesi G.; Brice A.; Bertram L.; Bozi M.; Barcikowska M.; Crosiers D.; Clarke C.E.; Facheris M.F.; Farrer M.; Garraux G.; Gispert S.; Auburger G.; Vilariño-Güell C.; Hadjigeorgiou G.M.; Hicks A.A.; Hattori N.; Jeon B.S.; Jamrozik Z.; Krygowska-Wajs A.; Lesage S.; Lill C.M.; Lin J.-J.; Lynch T.; Lichtner P.; Lang A.E.; Libioulle C.; Murata M.; Mok V.; Jasinska-Myga B.; Mellick G.D.; Morrison K.E.; Meitnger T.; Zimprich A.; Opala G.; Pramstaller P.P.; Pichler I.; Park S.S.; Quattrone A.; Rogaeva E.; Ross O.A.; Stefanis L.; Stockton J.D.; Satake W.; Silburn P.A.; Strom T.M.; Theuns J.; Tan E.K. ; Toda T.; Tomiyama H.; Uitti R.J.; Van Broeckhoven C.; Wirdefeldt K.; Wszolek Z.; Xiromerisiou G.; Yomono H.S.; Yueh K.-C.; Zhao Y.; Gasser T.; Maraganore D.; Krüger R.
6Feb-2013A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental diseaseKu, C.S. ; Polychronakos, C.; Tan, E.K. ; Naidoo, N. ; Pawitan, Y.; Roukos, D.H.; Mort, M.; Cooper, D.N.
72005A PDA-based ECG beat detector for home cardiac careGoh K.W.; Lavanya J.; Kim Y.; Tan E.K. ; Soh C.B.
8Jul-2013A prospective pilot study of repetitive transcranial magnetic stimulation for gait dysfunction in Vascular ParkinsonismYip, C.W.; Cheong, P.W.T.; Green, A.; Prakash, P.K.; Fook-Cheong, S.K.; Tan, E.K. ; Lo, Y.L.
9Apr-2010A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular diseaseNarasimhalu, K.; Effendy, S.; Sim, C.H.; Lee, J.M.; Chen, I.; Hia, S.B.; Xue, H.L.; Corrales, M.P.; Chang, H.M.; Wong, M.C.; Chen, C.P.; Tan, E.K. 
10Dec-2013A rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's diseaseFoo, J.-N.; Liany, H.; Bei, J.-X.; Yu, X.-Q.; Liu, J.; Au, W.-L.; Prakash, K.M.; Tan, L.C.; Tan, E.-K. 
112014A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson's disease modelsLi L.; Zhang C.-W.; Chen G.Y. ; Zhu B. ; Chai C. ; Xu Q.-H. ; Tan E.-K. ; Zhu Q. ; Lim K.-L. ; Yao S.Q. 
122016A trial of focused ultrasound thalamotomy for essential tremorTan E.-K. ; Chan L.-L. 
132005A variant in the HS1-BP3 gene is associated with familial essential tremorHiggins J.J.; Lombardi R.Q.; Pucilowska J.; Jankovic J.; Tan E.K. ; Rooney J.P.
142002A young man with parkinsonismThant Z.S.; Chan L.L.; Lim E.; Wong M.C.; Tan E.K. 
152007Acute ataxia, Graves' disease, and stiff person syndromeChia S.-Y.; Chua R.; Lo Y.-L. ; Wong M.-C. ; Chan L.-L. ; Tan E.-K. 
162001Alcohol dehydrogenase polymorphism and Parkinson's diseaseTan E.K. ; Nagamitsu S.; Matsuura T.; Khajavi M.; Jankovic J.; Ondo W.; Ashizawa T.
172003Alpha synuclein promoter and risk of Parkinson's disease: Microsatellite and allelic size variabilityTan E.-K. ; Tan C.; Shen H.; Chai A.; Lum S.-Y.; Teoh M.-L.; Yih Y.; Wong M.-C.; Zhao Y.
182005Alpha-synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patientsBerg D.; Niwar M.; Maass S.; Zimprich A.; Möller J.C.; Wuellner U.; Schmitz-Hübsch T.; Klein C.; Tan E.-K. ; Schöls L.; Marsh L.; Dawson T.M.; Janetzky B.; Müller T.; Woitalla D.; Kostic V.; Pramstaller P.P.; Oertel W.H.; Bauer P.; Krueger R.; Gasser T.; Riess O.
192004Alpha-synuclein haplotypes implicated in risk of Parkinson's diseaseTan E.-K. ; Chai A.; Teo Y.Y. ; Zhao Y.; Tan C.; Shen H.; Chandran V.R.; Teoh M.L.; Yih Y.; Pavanni R. ; Wong M.C. ; Puvan K. ; Lo Y.L. ; Yap E. 
202005Alpha-synuclein mRNA expression in sporadic Parkinson's diseaseTan E.-K. ; Chandran V.R.; Fook-Chong S. ; Shen H.; Yew K.; Teoh M.-L.; Yuen Y.; Zhao Y.